New, Corporate Not-For-Credit Session
This year APS has opened its door to the following not-for-credit session. The focus of these session are uniquely different from others at the meeting. Those presenting at these sessions either represent or will be discussing the views of a commercial interest. The sessions do not meet continuing education requirements and no CME, CNE, or CPE credit will be awarded to those attending these sessions.
The material discussed at these sessions do not represent the views or opinions of APS. These satellite events are not considered an official educational offering of the APS Annual Scientific Meeting. Should you have any questions about this please see APS staff.
Friday, May 7
6:30–8:30 pm
Corporate Not-for-Credit Dinner Session
REMS: What Do You Need to Know as a Prescriber?
Experiences with the First Opioid REMS Program*
The presentation will focus on the overall goal of the FOCUS program for Onsolis™, which is to mitigate the risk of Onsolis overdose, abuse, addiction, and serious complications due to medication errors. The program is designed to train prescribing clinicians, pharmacists, and patients/caregivers in the proper dosing and administration of Onsolis, to assure proper patient selection, and ultimately address such public health problems as abuse and misuse of opioids and methadone.
Faculty
Steven D. Passik, PhD
Associate Attending Psychologist
Memorial Sloan-Kettering Cancer Center
Associate Professor of Psychiatry
Weill College of Medicine
Cornell University Medical Center
New York, New York
Sidney Schnoll, MD, PhD
Vice President, Risk Management
Pinney Associates, Inc.
Bethesda, Maryland
Carrie D’Andrea, MS
Director of Clinical Programs
Medical & Scientific Affairs
MEDA Pharmaceuticals Inc.
Somerset, New Jersey
Carrie D’Andrea, MS
Director of Clinical Programs
Medical & Scientific Affairs
MEDA Pharmaceuticals Inc.
Somerset, New Jersey
This session is not eligible for CNE, CME, or CPE credit.
Supported by a grant from Meda Pharmaceutical. |